Automotive and Transportation Automotive and Transportation

Is Pfizer Inc. (PFE) the Best Weight Loss Stock to Buy Now According to Hedge Funds?


Published on 2024-12-17 08:03:17 - MSN
  Print publication without navigation

  • We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other weight loss stocks.

The article from MSN discusses whether Pfizer Inc. (PFE) is a good investment for those interested in the weight loss sector. It highlights that while Pfizer has not traditionally been known for weight loss drugs, its recent acquisition of Arena Pharmaceuticals has brought the drug candidate APD334 into its portfolio, which targets weight loss. The article notes that hedge funds have shown increased interest in Pfizer, with significant buying activity in recent quarters, suggesting confidence in its future in the weight loss market. However, it also points out that other companies like Novo Nordisk and Eli Lilly are currently leading with their respective weight loss drugs, Wegovy and Mounjaro. The piece concludes by suggesting that while Pfizer might not be the top choice for immediate weight loss stock investment, its strategic moves could position it well for future growth in this sector, especially if APD334 proves successful.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/health/weightloss/is-pfizer-inc-pfe-the-best-weight-loss-stock-to-buy-now-according-to-hedge-funds/ar-AA1w17PJ ]